Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1999-08-12
Original market date: See footnote 1
1995-12-31
Product name:
KABIKINASE - PWS 250000 UNIT/VIAL
DIN:
02126125 Electronic product monograph is not available
Company:
PHARMACIA & UPJOHN INC
1200
55 Standish Court
Mississauga
Ontario
Canada
L5R 4E3
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intracoronary , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
20:12.20
Anatomical Therapeutic Chemical (ATC): See footnote 4
B01AD01 STREPTOKINASE
Active ingredient group (AIG) number:See footnote5
0107605001
Active ingredient(s) | Strength |
---|---|
STREPTOKINASE | 250000 UNIT / VIAL |